CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: A meta-analysis

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3901-3911

  Xu, Chun Hua ^a   Wang, Qin ^b   Qian, Qian ^a   Zhan, Ping ^a   Yu, Li Ke ^a  

^a NANJING CHEST HOSPITAL   (China)

^b The 81st Hospital of PLA   (China)

Author keywords

CYP1A1; Lung cancer; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 1A1;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CYP1A1 GENE; DISEASE ASSOCIATION; ETHNICITY; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW;

EID: 84891484726     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0978-6     Document Type: Article

References (72)

1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123:21-49.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584-94.
3. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005;23:3175-85.
4. Rodriguez V, Tardon A, Kogevinas M, Prieto CS, Cueto A, Garcia M, et al. Lung cancer risk in iron and steel foundry workers: a nested case control study in Asturias, Spain. Am J Ind Med. 2000;38:644-50.
5. Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, et al. Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control. 2005;16:389-97.
6. Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201-13.
7. Butler JP, Post GB, Lioy PJ, Waldman JM, Greenberg A. Assessment of carcinogenic risk from personal exposure to benzo[a]pyrene in the Total Human Environmental Exposure Study (THEES). J Air Waste Manag Assoc. 1993;43:970-7.
8. Kawajiri K, Eguchi H, Nakachi K, et al. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res. 1996;56:72-6.
9. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS. 1990;1:131-3.
10. Houlston RS. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics. 2000;10(2):105-14.
11. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML, et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 2003;14(4):339-46.
12. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2008;59(2):155-63.
13. Zhan P, Qian Q, Yu LK. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2013;5(1):40-7. doi: 10.3978/j.issn.2072-1439.2013.01.02.
14. Zhan P, Qian Q, Wan B, Yan TD, Yu LK. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis. Transl Cancer Res. 2013;2:1. doi: 10.3978/j.issn.2218-676X.2013.02.08.
15. Zhan P, Wang Q, Qian Q, Yu LK. Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a meta-analysis. Transl Cancer Res. 2013;2(2):74-9. doi: 10.3978/j.issn.2218-676X.2013.04.13.
16. Zhan P, Wang Q, Qian Q, Yu LK. Risk of venous thromboembolism with the erythropoiesis-stimulating agents (ESAs) for the treatment of cancer-associated anemia: a meta-analysis of randomized control trials. Chin Clin Oncol. 2013. doi: 10.3978/j.issn.2304-3865.2013.01.02.
17. Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, et al. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. J Thorac Oncol. 2009;4(9):1094-103.
18. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-29.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
21. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15-7.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
23. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993;53:2994-9.
24. Alexandrie AK, Sundberg MI, Seidegård J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994;15:1785-90.
25. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis. 1995;16:2331-6.
26. Cantlay AM, Lamb D, Gillooly M, Norrman J, Morrison D, Smith CA, et al. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol. 1995;48:M210-4.
27. Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican and African-Americans. Cancer Epidemiol Biomarkers Prev. 1997;6:1075-80.
28. Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med. 1998;30:192-8.
29. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K, et al. Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarkers Prev. 1998;7:413-7.
30. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R, Garte S. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis. 1998;19:813-7.
31. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 1998;58:4858-63.
32. Xue KX, Lin X, Chen S, et al. Polymorphisms of the CYP1A1 and GSTM1 genes and lung cancer risk in Chinese population. Carcinog Teratog Mutagen. 1999;11:228-30 [in Chinese].
33. Hu YL, Qi Z. Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer. Chin J Med Genet. 1999;16:26-8 [in Chinese].
34. London SJ, Yuan JM, Coetzee GA, Gao YT, Ross RK, Yu MC. CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2000;9:987-91.
35. Xue KX, Xu L, Chen S, Ma GJ, Wu JZ. Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population. Chin J Med Genet. 2001;18:125-7 [in Chinese].
36. Ratnasinghe D, Tangrea JA, Stewart C, Bhat NK, Virtamo J, Albanes D, et al. Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking-lung cancer association. Anticancer Res. 2001;21:1295-9.
37. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 2001;174:35-44.
38. Song N, Tan W, Xing D, Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis. 2001;22:11-6.
39. Chen S, Xue K, Xu L, Ma G, Wu J. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res. 2001;458:41-7.
40. Zhou X, Shi Y, Zhou Y. The relationship between CYP1A1 genetic polymorphism and susceptibility to lung cancer. Chin J Environ Occup Med. 2002;19:355-67 [in Chinese].
41. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol. 2003;32:60-3.
42. Dong CT, Yang Q, Wang MZ, Dong QN. A study on the relationship between polymorphism of CYP1A1, Lack of GSTM1 and susceptibility to lung cancer. J Environ Occup Med. 2004;21:440-2 [in Chinese].
43. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem. 2004;266:1-9.
44. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, Gold B, et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett. 2004;214:197-204.
45. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M, McMillan A, et al. CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer. 2005;113:141-7.
46. Ng DP, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control. 2005;16:399-405.
47. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control. 2005;16:579-85.
48. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res. 2005;592:45-57.
49. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005;26:2207-12.
50. Li DR, Zhou QH, Guo ZL. Relationship between genetic polymorphism of CYP1A1 and lung cancer genetic susceptibility. Chin J Cancer Prev Treat. 2006;13:1765-8 [in Chinese].
51. Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, Unpunyo P, et al. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Cancer Epidemiol Biomarkers Prev. 2006;15:667-74.
52. Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer. 2007;57:135-42.
53. Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, et al. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer. 2007;55:255-62.
54. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer. 2008;60:40-6.
55. Gallegos-Arreola MP, Figuera-Villanueva LE, Troyo-Sanroman R, Morgán-Villela G, Puebla-Pérez AM, Flores-Marquez MR, et al. CYP1A12B and4 polymorphisms are associated with lung cancer susceptibility in Mexican patients. Int J Biol Markers. 2008;23:24-30.
56. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res. 2008;639:1-10.
57. Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem. 2009;322:73-9.
58. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis. 2009;30:626-35.
59. Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk W, Cressey R. Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet. 2009;195:143-9.
60. Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis. 2009;30:1161-9.
61. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, et al. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J. 2010;35:152-9.
62. Mota P, Moura DS, Vale MG, Coimbra H, Carvalho L, Regateiro F. CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer. Rev Port Pneumol. 2010;16(1):89-98.
63. Bai TY, Chang FH, Wang MJ, et al. Relationship between GSTT1 and CYP1A1 genetic polymorphisms and lung cancer susceptibility. Chin J Public Health. 2011;27:723-5.
64. Wang ZZ, Wang CB, Ma YG. Association of I462V polymorphism of gene with non-small cell lung cancer. Progr Anat Sci. 2011;17:361-3.
65. Atinkaya C, Taspinar M, Sakiragaoglu O, et al. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study. Hum Exp Toxicol. 2012;31(10):1074-80.
66. Islam MS, Ahmed MU, Sayeed MS, et al. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population. Clin Chim Acta. 2013;416:11-9.
67. Hirschhorn JN, Lohmueller K, Byrne E. A comprehensive review of genetic association studies. Genet Med. 2002;4:45-61.
68. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control. 1996;7:497-506.
69. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88(3-4):183-92.
70. Prescott E, Osler M, Hein HO, et al. Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology. 1998;9(1):79-83.
71. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999;59(14):3317-20.
72. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol. 2001;2(8):506-13.